"HM Puerta del Sur es un hospital médico-quirúrgico y materno-infantil dotado de la última innovación tecnológica y con la cartera de servicios más amplia destinada a dar servicio a la zona sur de Madrid. Con 25.000 m2, el hospital dispone de todas las especialidades médico-quirúrgicas, tanto de niños como de adultos, y Urgencias las 24 horas. Cuenta con un Servicio de Diagnóstico por Imagen totalmente digitalizado y con el primer PET-RM de adquisición simultánea de España, que tiene integrado un PET de última generación. Complementando al PET-RMN se encuentra la primera instalación en España de un sistema de RMN–HIFU destinado al tratamiento de enfermedades neurológicas."

During the past decade, HM Universitario Puerta del Sur CINAC (C.Integ.Neuroc);; Servicio de Psiquiatría conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "HM Universitario Puerta del Sur CINAC (C.Integ.Neuroc);; Servicio de Psiquiatría" #1 collaborator was "Hospital Nacional de Parapléjicos de Toledo" with 1 trials as a collaborator, "Hospital San Carlos, Madrid" with 1 trials as a collaborator, "Michael J. Fox Foundation for Parkinson's Research" with 1 trials as a collaborator and "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "HM Universitario Puerta del Sur CINAC (C.Integ.Neuroc);; Servicio de Psiquiatría" are "Alzheimer Disease" (2 trials), "Dyskinesia, Medication-Induced" (1 trials), "Essential Tremor" (1 trials), "Glioblastoma" (1 trials) and "Glioma, Malignant" (1 trials). Many other conditions were trialed in "HM Universitario Puerta del Sur CINAC (C.Integ.Neuroc);; Servicio de Psiquiatría" in a lesser frequency.

Most popular intervention types in "HM Universitario Puerta del Sur CINAC (C.Integ.Neuroc);; Servicio de Psiquiatría" are "Device" (4 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Gantenerumab" (2 trials), "Placebo" (2 trials), "sham" (2 trials), "tSMS" (2 trials) and "ExAblate Pallidotomy" (1 trials). Other intervention names were less common.

The vast majority of trials in "HM Universitario Puerta del Sur CINAC (C.Integ.Neuroc);; Servicio de Psiquiatría" are 7 trials for "All" genders.

Currently, there are NaN active trials in "HM Universitario Puerta del Sur CINAC (C.Integ.Neuroc);; Servicio de Psiquiatría". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in HM Universitario Puerta del Sur CINAC (C.Integ.Neuroc);; Servicio de Psiquiatría, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in HM Universitario Puerta del Sur CINAC (C.Integ.Neuroc);; Servicio de Psiquiatría, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".